![سامانه مدیریت نشریات علمی دانشگاه علوم پزشکی شیراز](./data/logo.png)
تعداد نشریات | 20 |
تعداد شمارهها | 1,119 |
تعداد مقالات | 10,261 |
تعداد مشاهده مقاله | 42,342,350 |
تعداد دریافت فایل اصل مقاله | 9,254,011 |
The Current Status of Pancreatic Cancer in Tunisia | ||
Middle East Journal of Cancer | ||
دوره 11، شماره 3 - شماره پیاپی 43، مهر 2020، صفحه 297-305 اصل مقاله (1.83 M) | ||
نوع مقاله: Original Article(s) | ||
شناسه دیجیتال (DOI): 10.30476/mejc.2020.81288.0 | ||
نویسندگان | ||
Imtinene Belaid* 1؛ Wiem Khechine2؛ Manel Limame2؛ Jihene Sahli2؛ Mohamed Amine Elghali3؛ Faten Ezzairi1؛ Makrem Hochlaf1؛ Imene Chabchoub1؛ Leila Ben Fatma1؛ Mohamed Ben Mabrouk4؛ Rached Letaief3؛ Ali Ben Ali4؛ Slim Ben Ahmed1 | ||
1Université de Sousse, Faculté de Médecine de Sousse, Department of Medical Oncology, Farhat Hached Hospital, Sousse, Tunisia | ||
2Université de Sousse, Faculté de Médecine de Sousse, Department of Familial and Community, Medicine, Sousse, Tunisia | ||
3Université de Sousse, Faculté de Médecine de Sousse, Department of Surgery, Farhat Hached Hospital, Sousse, Tunisia | ||
4Université de Sousse, Faculté de Médecine de Sousse, Department of Surgery, Sahloul Hospital, Sousse, Tunisia | ||
چکیده | ||
Background: Few studies have investigated pancreatic cancer in Tunisia and there are no reported survival data. The aim of this study was to analyze the epidemiologic profile, treatment modalities, and survival and prognostic factors of patients with pancreatic cancer in Tunisia. Method: In this retrospective study, we included patients treated between 2001 and 2016 for a histologically proven pancreatic cancer in the Department of Medical Oncology in Tunisia. Results: We examined 130 patients with a median age of 58.7 years and a sex ratio of 1.8. Thirty percent had surgery for a localized disease. Among resected patients, 14% received adjuvant chemotherapy. 14.5% of the patients with borderline resectable tumors underwent induction chemotherapy without leading to surgery. Palliative chemotherapy was administrated for unresectable locally advanced (14%) and metastatic (41.5%) tumors. Median overall survival for localized, locally advanced, and metastatic disease was 20.5, 10.4, and 6.3 months, respectively. Independent prognostic factors were female gender, performance status, tumor localization, and chemotherapy. Conclusions: Unlike what was published in the literature, patients in our study were younger and there was a male predominance. Survival rates were low even for localized stages. Treatment strategy, chemotherapy protocols, survival, and prognostic factors were in line with the literature. | ||
کلیدواژهها | ||
Pancreatic neoplasms؛ Epidemiology؛ Therapeutics؛ Prognosis | ||
اصل مقاله | ||
How to cite this article: Belaid I, Khechine W, Limame M, Sahli J, Elghali MA, Ezzairi F, et al. The current status of pancreatic cancer in Tunisia. Middle East J Cancer. 2020;11(3):297-305. doi:10.30476/mejc.2020.81288.0. | ||
آمار تعداد مشاهده مقاله: 2,435 تعداد دریافت فایل اصل مقاله: 1,773 |